Latest Partnerships News

Noronex Limited has kicked off a significant 7,000m reverse circulation drilling campaign at its Powerline Copper Project in Namibia, aiming to unlock new copper-silver deposits along the Kalahari Copper Belt. Funded by South32 under an earn-in agreement, this program targets promising domal structures identified by aeromagnetic surveys.

Equinox Resources has agreed to sell its Alturas Antimony Project in British Columbia to Maxus Mining, freeing up capital and focus for its core iron ore ambitions in Western Australia.

Perseus Mining has secured presidential approval to develop the CMA underground project at Yaouré, marking a pivotal expansion in Côte d’Ivoire’s gold mining sector. The project promises to extend mine life to 2035 with production ramping up by early 2027.

Xamble Group Limited has successfully closed a partially underwritten rights issue, raising approximately A$1.36 million to accelerate its digital marketing platform expansion in Southeast Asia.

BCAL Diagnostics has partnered with US-based ClearNote Health to exclusively distribute innovative blood tests for early detection of pancreatic and ovarian cancers in Australia and New Zealand, starting early 2026.

Blue Star Helium has decided not to exercise its purchase option on key Colorado helium assets after thorough evaluation, signaling a strategic pivot in its growth approach.

Western Gold Resources Limited has had its trading suspension lifted following the release of initial assay results from its Duke Gold project and a response to an ASX price and volume query.

Tempest Minerals has secured regulatory approval to begin Phase I drilling at its Halo prospect within the Yalgoo Project, targeting iron, copper, and gold. A heritage survey with the Badimia People is currently in progress, marking a key step toward unlocking the site's potential.

Neurizon Therapeutics has raised $5 million through an institutional placement to advance its lead ALS drug candidate NUZ-001 into a pivotal clinical trial, pending FDA clearance. The capital injection also supports manufacturing and pre-clinical development efforts.

Pathkey.AI has upgraded its TrialKey platform to include drug-level molecular and pharmacokinetic features, enhancing clinical trial predictions and opening doors to AI-driven drug discovery.

Renascor Resources has begun construction of its Purified Spherical Graphite demonstration facility in Adelaide, aiming to showcase an innovative HF-free purification process and disrupt China’s near-monopoly on PSG supply.

PARKD Limited has clinched exclusive national rights to prefabricate key modular building components from Fielders, positioning itself to capitalize on booming construction sectors like data centres and self-storage across Australia.